Viemed Healthcare Operating Income Over Time
| VMD Stock | USD 8.32 0.10 1.19% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Viemed Healthcare Performance and Viemed Healthcare Correlation. Will Health Care Equipment & Supplies sector continue expanding? Could Viemed diversify its offerings? Factors like these will boost the valuation of Viemed Healthcare. If investors know Viemed will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Viemed Healthcare data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0.1) | Earnings Share 0.34 | Revenue Per Share | Quarterly Revenue Growth 0.24 | Return On Assets |
Viemed Healthcare's market price often diverges from its book value, the accounting figure shown on Viemed's balance sheet. Smart investors calculate Viemed Healthcare's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Viemed Healthcare's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Viemed Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Viemed Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Viemed Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Operating Income Analysis
Compare Viemed Healthcare and related stocks such as Allurion Technologies, Co Diagnostics, and Vivos Therapeutics Operating Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ALUR | (5.2 K) | (5.2 K) | (5.2 K) | (5.2 K) | (5.2 K) | (5.2 K) | (5.2 K) | (5.2 K) | (5.2 K) | (5.2 K) | (5.2 K) | (12.5 M) | (32 M) | (79.1 M) | (50.2 M) | (45.2 M) | (47.4 M) |
| CODX | (1 M) | (1 M) | (1 M) | (1 M) | (1 M) | (2 M) | (1.7 M) | (4.6 M) | (6.1 M) | (5.9 M) | 41.7 M | 46.1 M | (27 M) | (42.7 M) | (40.1 M) | (36.1 M) | (34.3 M) |
| VVOS | (8.3 M) | (8.3 M) | (8.3 M) | (8.3 M) | (8.3 M) | (8.3 M) | (8.3 M) | (8.3 M) | (8.3 M) | (10.6 M) | (8.7 M) | (19.5 M) | (25 M) | (17.3 M) | (11.2 M) | (10.1 M) | (10.6 M) |
| EKSO | (14.2 M) | (14.2 M) | (14.2 M) | (12.3 K) | (16.8 M) | (21.6 M) | (27.6 M) | (31.6 M) | (27 M) | (16.6 M) | (12.9 M) | (13.8 M) | (15.6 M) | (15.1 M) | (10.5 M) | (12 M) | (12.6 M) |
| ADGM | (13.5 K) | (13.5 K) | (13.5 K) | (13.5 K) | (13.5 K) | (13.5 K) | (13.5 K) | (13.5 K) | (13.5 K) | (13.5 K) | (13.5 K) | (20.6 M) | (23.9 M) | (27.9 M) | (62.5 M) | (56.2 M) | (53.4 M) |
| AYTU | (46.9 K) | (56.4 K) | (52.4 K) | (6.3 M) | (7.6 M) | (21.7 M) | (20.1 M) | (19.7 M) | (16.8 M) | (21.1 M) | (58.9 M) | (109.9 M) | (17.1 M) | (1.6 M) | (7.8 M) | (7 M) | (7.4 M) |
| GOVX | (1.3 M) | (2.3 M) | (2.1 M) | (2.3 M) | (2.7 M) | (2.7 M) | (3.3 M) | (2.2 M) | (2.6 M) | (2.4 M) | (2.8 M) | (18.7 M) | (14 M) | (26.7 M) | (25.1 M) | (22.6 M) | (21.5 M) |
| PRPH | (700 K) | (2.7 M) | (1.1 M) | 416 K | (7.8 M) | (3.6 M) | (2.7 M) | (4 M) | (1.6 M) | (3.2 M) | (4 M) | 9.8 M | 23.6 M | (21.6 M) | (38.6 M) | (34.8 M) | (33 M) |
Viemed Healthcare and related stocks such as Allurion Technologies, Co Diagnostics, and Vivos Therapeutics Operating Income description
Operating Income is the amount of profit realized from Viemed Healthcare operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Viemed Healthcare is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.My Equities
My Current Equities and Potential Positions
| Viemed Healthcare | VMD |
| Classification | Health Management |
| Business Address | 625 East Kaliste |
| Exchange | NASDAQ Exchange |
USD 8.32
Check out Viemed Healthcare Performance and Viemed Healthcare Correlation. For information on how to trade Viemed Stock refer to our How to Trade Viemed Stock guide.You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Viemed Healthcare technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.